Apolizumab
Jump to navigation
Jump to search
Template:Drugbox-mab Apolizumab is a humanized monoclonal antibody that is being studied as a treatment for hematologic cancers.[1]
References
- ↑ Bayes M, Rabasseda X, Prous J (2003). "Gateways to clinical trials". Methods Find Exp Clin Pharmacol. 25 (9): 747–71. PMID 14685303.
 | This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |